Cardinal Health
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Cardinal Health (CAH) Business News
Track Cardinal Health in real time with a live news feed covering Cardinal Health stock news, official press releases, company announcements, and an archive of historical Cardinal Health news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Best Dividend Aristocrats For March 2026
Best Dividend Aristocrats For March 2026
3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR
Cardinal Health, Inc. $CAH Shares Acquired by Cozad Asset Management Inc.
Cardinal Health report highlights cost savings and provider confidence in biosimilars
Cardinal Health, Inc. $CAH Shares Bought by Counterpoint Mutual Funds LLC
Raiffeisen Bank International AG Has $252,000 Stake in Cardinal Health, Inc. $CAH
Axxcess Wealth Management LLC Decreases Position in Cardinal Health, Inc. $CAH
Q4 Earnings: These Buy-Rated Stocks Crushed Expectations
BOOT & 3 Other Stocks With Strong Interest Coverage to Buy Now
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.
22%, below last year's trend and potentially signaling headwinds.
Best Dividend Aristocrats For March 2026
Seeking AlphaThe ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.
22%, below last year's trend and potentially signaling headwinds.
Best Dividend Aristocrats For March 2026
Seeking AlphaThe ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.
22%, below last year's trend and potentially signaling headwinds.
3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR
Zacks Investment ResearchThe 2025 Q4 earnings season is pretty much over following the highly-awaited NVIDIA release. Throughout the period, these three releases have stood out.
Read full article
Cardinal Health, Inc. $CAH Shares Acquired by Cozad Asset Management Inc.
Defense WorldCozad Asset Management Inc. lifted its position in Cardinal Health, Inc. (NYSE: CAH) by 23.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 32,266 shares of the company's stock after purchasing an additional 6,185 shares during the quarter.
Cardinal Health report highlights cost savings and provider confidence in biosimilars
PRNewsWireNew analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption and accessibility gains. DUBLIN, Ohio, Feb. 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings biosimilars have delivered to the U.S. healthcare system and the strong confidence providers have in these treatments.
Cardinal Health, Inc. $CAH Shares Bought by Counterpoint Mutual Funds LLC
Defense WorldCounterpoint Mutual Funds LLC raised its holdings in shares of Cardinal Health, Inc. (NYSE: CAH) by 51.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,251 shares of the company's stock after buying an additional 5,877 shares during the period. Counterpoint Mutual
Read full article
Raiffeisen Bank International AG Has $252,000 Stake in Cardinal Health, Inc. $CAH
Defense WorldRaiffeisen Bank International AG reduced its stake in shares of Cardinal Health, Inc. (NYSE: CAH) by 71.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,633 shares of the company's stock after selling 4,108 shares during the quarter. Raiffeisen Bank International
Read full article
Axxcess Wealth Management LLC Decreases Position in Cardinal Health, Inc. $CAH
Defense WorldAxxcess Wealth Management LLC cut its holdings in Cardinal Health, Inc. (NYSE: CAH) by 20.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,141 shares of the company's stock after selling 3,166 shares during the period. Axxcess Wealth Management LLC's
Read full article
Q4 Earnings: These Buy-Rated Stocks Crushed Expectations
Zacks Investment ResearchThe 2025 Q4 earnings cycle keeps rolling along, with overall growth remaining strong. Specifically, these companies knocked it out of the park, with both also sporting a favorable Zacks Rank.
Read full article
BOOT & 3 Other Stocks With Strong Interest Coverage to Buy Now
Zacks Investment ResearchBOOT joins EAT, TPR and CAH on a screen for strong interest coverage, solid volume and growth, spotlighting four stocks that made the cut.
Read full article
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
Zacks Investment ResearchInvestors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read full article